Prospective PTCTC trial of myeloablative haplo-BMT with posttransplant cyclophosphamide for pediatric acute leukemias

Authors

Juan C Fierro-Pineda, Johns Hopkins University
Andrew Cluster, Washington University School of Medicine in St. Louis
et al.

Journal

Blood Advances

Publication Date

9-26-2023

Volume

7

Issue

18

First Page

5639

Last Page

5648

Document Type

Open Access Publication

DOI

10.1182/bloodadvances.2023010281

Rights and Permissions

Fierro-Pineda JC, Tsai HL, Blackford A, Cluster A, Caywood E, Dalal J, Davis J, Egeler M, Huo J, Hudspeth M, Keating A, Kelly SS, Krueger J, Lee D, Lehmann L, Madden L, Oshrine B, Pulsipher MA, Fry T, Symons HJ. Prospective PTCTC trial of myeloablative haplo-BMT with posttransplant cyclophosphamide for pediatric acute leukemias. Blood Adv. 2023 Sep 26;7(18):5639-5648. doi: 10.1182/bloodadvances.2023010281. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

Recommended Citation

Fierro-Pineda, Juan C; Cluster, Andrew; and et al., "Prospective PTCTC trial of myeloablative haplo-BMT with posttransplant cyclophosphamide for pediatric acute leukemias." Blood Advances. 7, 18. 5639 - 5648. (2023).
https://digitalcommons.wustl.edu/oa_4/2999